Literature DB >> 8412802

Synthetic selective inhibitors of thrombin.

S Okamoto1, A Hijikata-Okunomiya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8412802     DOI： 10.1016/0076-6879(93)22022-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

1.  Acute ischemic stroke successfully treated using sequenced intravenous and intra-arterial thrombolysis and argatroban anticoagulation: a case study.

Authors:  Marian P LaMonte; M J Bernadette Stallmeyer
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300

Review 2.  Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.

Authors:  Marcie J Hursting; Joseph Soffer
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  The nature of the stable blood clot procoagulant activities.

Authors:  Thomas Orfeo; Kathleen E Brummel-Ziedins; Matthew Gissel; Saulius Butenas; Kenneth G Mann
Journal:  J Biol Chem       Date:  2008-02-11       Impact factor: 5.157

4.  Anticoagulants and the propagation phase of thrombin generation.

Authors:  Thomas Orfeo; Matthew Gissel; Saulius Butenas; Anetta Undas; Kathleen E Brummel-Ziedins; Kenneth G Mann
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

5.  Combination of therapeutic hypothermia and other neuroprotective strategies after an ischemic cerebral insult.

Authors:  Joline Goossens; Saïd Hachimi-Idrissi
Journal:  Curr Neuropharmacol       Date:  2014-09       Impact factor: 7.363

6.  Efficacy and safety of argatroban in treatment of acute ischemic stroke: A meta-analysis.

Authors:  Bin Lv; Fang-Fang Guo; Jia-Cai Lin; Feng Jing
Journal:  World J Clin Cases       Date:  2022-01-14       Impact factor: 1.337
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.